# Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer

> **NCT02790944** · — · COMPLETED · sponsor: **Ambry Genetics** · enrollment: 300 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

- **GENETIC:** Multi-gene Next Generation Sequencing Panel

## Key facts

- **NCT ID:** NCT02790944
- **Lead sponsor:** Ambry Genetics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-04
- **Primary completion:** 2020-08-15
- **Final completion:** 2020-08-15
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2020-08-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02790944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02790944, "Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02790944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*